Principles of peritoneal dialysis

EDTNA-ERCA Journal

Volumn 31, Issue 3, 2005, Pages 124-129

  Alscher, Dominik Mark ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; DIALYSIS FLUID; GENTAMICIN; PSEUDOMONIC ACID;

ANTIBIOTIC PROPHYLAXIS; CALCIFICATION; ESCHERICHIA COLI; HEMODIALYSIS; HERNIA; HUMAN; INFECTIOUS COMPLICATION; INTERMETHOD COMPARISON; KIDNEY FAILURE; MORTALITY; PATHOPHYSIOLOGY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PREVALENCE; PSEUDOMONAS AERUGINOSA; REVIEW; SCLEROSIS; SOCIOECONOMICS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 29044435876     PISSN: 1019083X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2005.tb00410.x     Document Type: Review

References (30)

1. Cancarini, G.C., et al., The peritoneum during peritoneal dialysis. Perit Dial Int 2000, 20 (Suppl 3): 537-86.
2. Flessner, M.F.: Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 1991, 2: 122-35.
3. Nolph, K.D., J.E. Hano, and P.E. Teschan: Peritoneal sodium transport during hypertonic peritoneal dialysis. Physiologic mechanisms and clinical implications. Ann Intern Med 1969, 70(5): 931-41.
4. Khanna, R. and R. Mactier: Role of lymphatics in peritoneal dialysis. Blood Purif 1992, 10(3-4): 163-72.
5. Pannekeet, M.M., et al.: Thestandard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995, 48(3): 866-75.
6. Gokal, R., et al.: Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. (Official report from the International Society for Peritoneal Dialysis). Perit Dial lnt 1998, 18(1): 11-33.
7. Strippoli, G.F., et al.: Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004, 4: CD004680.
8. Eklund, B.H., et al.: Peritoneal dialysis access: prospective randomized comparison of the Swan neck and Tenckhoff catheters. Perit Dial Int 1995, 15(8): 353-6.
9. Quellhorst, E.: Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol 2002, 13 (Suppl 1): S92-6.
10. Rogachev, B., et al.: Effect of bicarbonate-based dialysis solutions on intracellular pH (pHi) and TNFalpha production by peritoneal macrophages. Perit Dial Int 1997, 17(6): 546-53.
11. Alscher, D.M., et al.: A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function. Nephron 2000, 86(1): 62-9.
12. Williams, J.D., et al.: The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004, 66(1): 408-18.
13. Mistry, C.D., R. Gokal, and E. Peers: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994, 46(2): 496-503.
14. Amid, G., et al.: Ten years after MIDAS: icodextrin lights and shadows. Contrib Nephrol 2003, 140: 76-81.
15. Basile, C., et al.: The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome. J Nephrol 2003, 16(3): 384-6.
16. Jones, M., et al.: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis 1998, 32(5): 761-9.
17. Nelson, C.B., et al.: Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992, 3(5): 1147-55.
18. Vonesh, E.F. and J. Moran: Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999, 10(2): 354-65.
19. Fenton, S.S., et al.: Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997, 30(3) : 334-42.
20. Collins A.J., et al.: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34 (6) 1 065-74.
21. Korevaar, J.C., et al.: Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003, 64(6): 2222-8.
22. Bernardini, J., et al.: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005, 16(2): 539-45.
23. Strippoli, G.F., et al.: Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol 2004, 15(10): 2735-46.
24. Flanigan, M. and R. Gokal: Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int 2005, 25(2): 132-9.
25. Kim, D.K., et al.: Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004, 24(5): 424-32.
26. Luzar, M.A., et al.: Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990, 322(8): 505-9.
27. Piraino, B., et al.: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005, 25(2): 107-31.
28. Williams, J.D., et al.: The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003, (88): S43-9.
29. Bradley, J.A., et al.: Sclerosing peritonitis after CAPD. Lancet 1983, 2(8349): 572-3.
30. Afthentopoulos, I.E., et al.: Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature. Adv Ren Replace Ther 1998, 5(3): 157-67.